These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6768163)

  • 1. Effect of glycosaminoglycans on thrombin-induced clotting of normal and antithrombin III-deficient plasmas.
    Kindness G; Long WF; Williamson FB; Edward M; Winter JH; Bennett NB
    Thromb Res; 1980 Feb 1-15; 17(3-4):539-44. PubMed ID: 6768163
    [No Abstract]   [Full Text] [Related]  

  • 2. The anticoagulant effect of heparan sulfate and dermatan sulfate.
    Teien AN; Abildgaard U; Höök M
    Thromb Res; 1976 Jun; 8(6):859-67. PubMed ID: 134464
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant effects of sulphated polysaccharides in normal and antithrombin III-deficient plasmas.
    Kindness G; Long WF; Williamson FB
    Br J Pharmacol; 1980 Aug; 69(4):675-7. PubMed ID: 6159941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
    Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.
    Ofosu FA; Modi GJ; Smith LM; Cerskus AL; Hirsh J; Blajchman MA
    Blood; 1984 Sep; 64(3):742-7. PubMed ID: 6235872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis.
    Chang X; Yamada R; Yamamoto K
    Arthritis Res Ther; 2005; 7(2):R268-73. PubMed ID: 15743473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation protein function: enhancement of the anticoagulant effect of acetaldehyde by sulfated glycosaminoglycans.
    Brecher AS; Adamu MT
    Dig Dis Sci; 2001 Sep; 46(9):2033-42. PubMed ID: 11575460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danaparoid: an anti-thrombotic agent without major impact on triglyceride hydrolysis capacity in humans.
    Mikhailidis DP; Jagroop IA
    J Intern Med; 1998 Aug; 244(2):184. PubMed ID: 10095808
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
    Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant activity of dermatan polysulfates.
    Akiyama F; Seno N; Yoshida K
    Tohoku J Exp Med; 1982 Apr; 136(4):359-65. PubMed ID: 6808700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiocoagulant activity of chondroitin sulfate A, B and C.--co-operative action with heparin cofactor (author's transl)].
    Shiba T; Takeuchi S; Awazu S; Igarashi M; Asada T
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):560-3. PubMed ID: 696196
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C.
    Fernández JA; Petäjä J; Griffin JH
    Thromb Haemost; 1999 Nov; 82(5):1462-8. PubMed ID: 10595639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial in vivo neutralisation of plasma anticoagulant effects of Lomoparan (Org 10172) by protamine chloride.
    Stiekema JC; Wijnand HP; ten Cate H; ten Cate JW; Harenberg J; Egberts JF; van Dinther TG
    Thromb Res; 1991 Jul; 63(1):157-67. PubMed ID: 1948817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of glycosaminoglycans and protamine chloridrate on platelet aggregation induced by collagen and thrombin.
    Luzzatto G; Paolini R; Stevanato F; Simioni P; Cella G
    Angiology; 1989 Mar; 40(3):170-4. PubMed ID: 2916768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anticoagulant activity of dermatan sulphates: evidence against the involvement of antithrombin III.
    Kindness G; Long WF; Williamson FB
    Br J Pharmacol; 1981 Jan; 72(1):81-8. PubMed ID: 7225714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anticoagulant activity of dermatan sulphates.
    Long WF; Williamson FB; Kindness G; Edward M
    Thromb Res; 1980 May 1-15; 18(3-4):493-503. PubMed ID: 7414544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.